103 related articles for article (PubMed ID: 18782562)
1. Striatal 19S Rpt6 deficit is related to alpha-synuclein accumulation in MPTP-treated mice.
Liu B; Shi Q; Ma S; Feng N; Li J; Wang L; Wang X
Biochem Biophys Res Commun; 2008 Nov; 376(2):277-82. PubMed ID: 18782562
[TBL] [Abstract][Full Text] [Related]
2. Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration.
Drolet RE; Behrouz B; Lookingland KJ; Goudreau JL
Neurotoxicology; 2004 Sep; 25(5):761-9. PubMed ID: 15288507
[TBL] [Abstract][Full Text] [Related]
3. Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and alpha-synuclein inclusions.
Gibrat C; Saint-Pierre M; Bousquet M; Lévesque D; Rouillard C; Cicchetti F
J Neurochem; 2009 Jun; 109(5):1469-82. PubMed ID: 19457163
[TBL] [Abstract][Full Text] [Related]
4. Vulnerability of peripheral catecholaminergic neurons to MPTP is not regulated by alpha-synuclein.
Cano-Jaimez M; Pérez-Sánchez F; Milán M; Buendía P; Ambrosio S; Fariñas I
Neurobiol Dis; 2010 Apr; 38(1):92-103. PubMed ID: 20079841
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice.
Alvarez-Fischer D; Henze C; Strenzke C; Westrich J; Ferger B; Höglinger GU; Oertel WH; Hartmann A
Exp Neurol; 2008 Mar; 210(1):182-93. PubMed ID: 18053987
[TBL] [Abstract][Full Text] [Related]
6. Damage to the nigrostriatal system in the MPTP-treated SAMP8 mouse.
Liu J; Wang YY; Liu L; Wang QD; Yuan ZY; Zhang ZX; Gu P; Wang MW
Neurosci Lett; 2008 Dec; 448(2):184-8. PubMed ID: 18977411
[TBL] [Abstract][Full Text] [Related]
7. Increased sensitivity to MPTP in human alpha-synuclein A30P transgenic mice.
Nieto M; Gil-Bea FJ; Dalfó E; Cuadrado M; Cabodevilla F; Sánchez B; Catena S; Sesma T; Ribé E; Ferrer I; Ramírez MJ; Gómez-Isla T
Neurobiol Aging; 2006 Jun; 27(6):848-56. PubMed ID: 16006012
[TBL] [Abstract][Full Text] [Related]
8. N(ɛ)-(carboxymethyl)lysine linkage to α-synuclein and involvement of advanced glycation end products in α-synuclein deposits in an MPTP-intoxicated mouse model.
Choi YG; Lim S
Biochimie; 2010 Oct; 92(10):1379-86. PubMed ID: 20624443
[TBL] [Abstract][Full Text] [Related]
9. Broad neuroprotective profile of nicotinamide in different mouse models of MPTP-induced parkinsonism.
Anderson DW; Bradbury KA; Schneider JS
Eur J Neurosci; 2008 Aug; 28(3):610-7. PubMed ID: 18702732
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
Kim NK; Choi BH; Huang X; Snyder BJ; Bukhari S; Kong TH; Park H; Park HC; Park SR; Ha Y
Eur J Neurosci; 2009 Mar; 29(5):891-900. PubMed ID: 19245369
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptors modulate striatal metabotropic receptor type 5 in intact and MPTP male mice model of Parkinson's disease.
Al-Sweidi S; Morissette M; Di Paolo T
J Steroid Biochem Mol Biol; 2016 Jul; 161():84-91. PubMed ID: 26873133
[TBL] [Abstract][Full Text] [Related]
12. MPTP-induced model of Parkinson's disease in cytochrome P450 2E1 knockout mice.
Viaggi C; Vaglini F; Pardini C; Caramelli A; Corsini GU
Neuropharmacology; 2009 Jun; 56(8):1075-81. PubMed ID: 19298832
[TBL] [Abstract][Full Text] [Related]
13. Effect of caffeine on the expression of cytochrome P450 1A2, adenosine A2A receptor and dopamine transporter in control and 1-methyl 4-phenyl 1, 2, 3, 6-tetrahydropyridine treated mouse striatum.
Singh S; Singh K; Gupta SP; Patel DK; Singh VK; Singh RK; Singh MP
Brain Res; 2009 Aug; 1283():115-26. PubMed ID: 19520064
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol alleviates MPTP-induced motor impairments and pathological changes by autophagic degradation of α-synuclein via SIRT1-deacetylated LC3.
Guo YJ; Dong SY; Cui XX; Feng Y; Liu T; Yin M; Kuo SH; Tan EK; Zhao WJ; Wu YC
Mol Nutr Food Res; 2016 Oct; 60(10):2161-2175. PubMed ID: 27296520
[TBL] [Abstract][Full Text] [Related]
15. [Effection of Qing-Xuan tablets on behavior pattern and striatal TNF-alpha of Parkinson model mice].
Yang XX; Yang L; Huo QL; Liu MN; Lin XX; Liu SJ
Zhong Yao Cai; 2009 Oct; 32(10):1560-3. PubMed ID: 20112721
[TBL] [Abstract][Full Text] [Related]
16. Mice lacking alpha-synuclein are resistant to mitochondrial toxins.
Klivenyi P; Siwek D; Gardian G; Yang L; Starkov A; Cleren C; Ferrante RJ; Kowall NW; Abeliovich A; Beal MF
Neurobiol Dis; 2006 Mar; 21(3):541-8. PubMed ID: 16298531
[TBL] [Abstract][Full Text] [Related]
17. Spinal cord degeneration in C57BL/6N mice following induction of experimental parkinsonism with MPTP.
Samantaray S; Knaryan VH; Butler JT; Ray SK; Banik NL
J Neurochem; 2008 Mar; 104(5):1309-20. PubMed ID: 18036149
[TBL] [Abstract][Full Text] [Related]
18. Strain-specific sensitivity to MPTP of C57BL/6 and BALB/c mice is age dependent.
Filipov NM; Norwood AB; Sistrunk SC
Neuroreport; 2009 May; 20(7):713-7. PubMed ID: 19349914
[TBL] [Abstract][Full Text] [Related]
19. Effects of estrogens on striatal damage after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in male and female mice.
Ookubo M; Yokoyama H; Takagi S; Kato H; Araki T
Mol Cell Endocrinol; 2008 Dec; 296(1-2):87-93. PubMed ID: 18755240
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of adenosine increase in the striatum in common marmoset parkinsonism induced by MPTP.
Nomoto M; Shimizu T; Iwata S; Kaseda S; Fukuda T
Adv Neurol; 1999; 80():125-8. PubMed ID: 10410711
[No Abstract] [Full Text] [Related]
[Next] [New Search]
